WallStreetZenWallStreetZen

NYSE: PHR
Phreesia Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for PHR

Based on 15 analysts offering 12 month price targets for Phreesia Inc

Min Forecast
$10.00-0.4%
Avg Forecast
$14.13+40.77%
Max Forecast
$20.00+99.2%

Should I buy or sell PHR stock?

Based on 17 analysts offering ratings for Phreesia Inc.

Buy
Strong Buy
5 analysts 29.41%
Buy
4 analysts 23.53%
Hold
8 analysts 47.06%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although PHR's forecast from analysts indicates a "Buy", our proven Zen Rating quant model rates PHR as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +5.11% per year. Learn More

Be the first to know when Wall Street analysts revise their PHR stock forecasts and price targets.

PHR stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-09-08
lockedlocked$00.00+00.00%2026-09-04
lockedlocked$00.00+00.00%2026-09-04
lockedlocked$00.00+00.00%2026-09-03
lockedlocked$00.00+00.00%2026-09-03
Wells Fargo
Top 33%
68
HoldMaintains$10.00-0.40%2026-09-03
Canaccord Genuity
Bottom 3%
3
Strong BuyMaintains$16.00+59.36%2026-09-03
Needham
Bottom 5%
5
BuyReiterates$14.00+39.44%2026-09-03
Truist Securities
Bottom 1%
1
HoldMaintains$12.00+19.52%2026-05-29
Citigroup
Bottom 4%
4
HoldMaintains$12.00+19.52%2026-05-28

1 of 2

Forecast return on equity

Is PHR forecast to generate an efficient return?

Company
13%
Industry
22.66%
Market
168.71%
PHR's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is PHR forecast to generate an efficient return on assets?

Company
7.47%
Industry
16.87%
PHR is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

PHR earnings per share forecast

What is PHR's earnings per share in the next 3 years based on estimates from 20 analysts?

Avg 1 year Forecast
$0.40+137.76%
Avg 2 year Forecast
$0.68+297.35%
Avg 3 year Forecast
$1.70+897.76%
PHR's earnings are forecast to... subscribe to Premium to read more.
Forecast High Earnings Growth Forecast

PHR revenue forecast

What is PHR's revenue in the next 3 years based on estimates from 20 analysts?

Avg 1 year Forecast
$520.8M+2.57%
Avg 2 year Forecast
$542.0M+6.73%
Avg 3 year Forecast
$565.7M+11.4%
PHR's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

PHR earnings growth forecast

How is PHR forecast to perform vs Health Information Services companies and vs the US market?

Company
58.39%
Industry
18.11%
Market
31.22%
PHR's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
PHR's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
PHR's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

PHR revenue growth forecast

How is PHR forecast to perform vs Health Information Services companies and vs the US market?

Company
2.5%
Industry
7.01%
Market
13.78%
PHR's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
PHR's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

PHR vs Health Information Service Stocks

TickerPricePrice TargetUp/downsideConsensus
PHR$10.04$14.13+40.77%Buy
WEAV$7.29$7.40+1.51%Hold
SOPH$8.19$11.50+40.42%Strong Buy
CTEV$30.81$39.50+28.21%Strong Buy
NRC$20.56$26.00+26.46%Buy
View Top Health Information Service Stocks

Phreesia Stock Forecast FAQ

Is Phreesia Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 17 Wall Street analysts covering (NYSE: PHR) stock is to Buy PHR stock.

Out of 17 analysts, 5 (29.41%) are recommending PHR as a Strong Buy, 4 (23.53%) are recommending PHR as a Buy, 8 (47.06%) are recommending PHR as a Hold, 0 (0%) are recommending PHR as a Sell, and 0 (0%) are recommending PHR as a Strong Sell.

If you're new to stock investing, here's how to buy Phreesia stock.

What is PHR's earnings growth forecast for 2027-2029?

(NYSE: PHR) Phreesia's forecast annual earnings growth rate of 58.39% is forecast to beat the US Health Information Services industry's average forecast earnings growth rate of 18.11%, and it is also forecast to beat the US market's average forecast earnings growth rate of 31.22%.

Phreesia's earnings in 2026 is $10,447,000.On average, 20 Wall Street analysts forecast PHR's earnings for 2027 to be $25,089,076, with the lowest PHR earnings forecast at $12,165,905, and the highest PHR earnings forecast at $43,015,164. On average, 19 Wall Street analysts forecast PHR's earnings for 2028 to be $41,928,923, with the lowest PHR earnings forecast at $26,156,696, and the highest PHR earnings forecast at $62,567,512.

In 2029, PHR is forecast to generate $105,284,735 in earnings, with the lowest earnings forecast at $99,077,641 and the highest earnings forecast at $112,751,870.

What is PHR's revenue growth forecast for 2027-2029?

(NYSE: PHR) Phreesia's forecast annual revenue growth rate of 2.5% is not forecast to beat the US Health Information Services industry's average forecast revenue growth rate of 7.01%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.78%.

Phreesia's revenue in 2026 is $507,793,000.On average, 20 Wall Street analysts forecast PHR's revenue for 2027 to be $32,328,409,764, with the lowest PHR revenue forecast at $31,040,437,676, and the highest PHR revenue forecast at $33,890,735,424. On average, 19 Wall Street analysts forecast PHR's revenue for 2028 to be $33,641,830,939, with the lowest PHR revenue forecast at $30,576,147,014, and the highest PHR revenue forecast at $36,537,440,476.

In 2029, PHR is forecast to generate $35,111,050,183 in revenue, with the lowest revenue forecast at $31,965,915,451 and the highest revenue forecast at $38,929,033,948.

What is PHR's forecast return on assets (ROA) for 2027-2029?

(NYSE: PHR) forecast ROA is 7.47%, which is lower than the forecast US Health Information Services industry average of 16.87%.

What is PHR's Price Target?

According to 15 Wall Street analysts that have issued a 1 year PHR price target, the average PHR price target is $14.13, with the highest PHR stock price forecast at $20.00 and the lowest PHR stock price forecast at $10.00.

On average, Wall Street analysts predict that Phreesia's share price could reach $14.13 by Sep 8, 2027. The average Phreesia stock price prediction forecasts a potential upside of 40.77% from the current PHR share price of $10.04.

What is PHR's Earnings Per Share (EPS) forecast for 2027-2029?

(NYSE: PHR) Phreesia's current Earnings Per Share (EPS) is $0.17. On average, analysts forecast that PHR's EPS will be $0.40 for 2027, with the lowest EPS forecast at $0.20, and the highest EPS forecast at $0.69. On average, analysts forecast that PHR's EPS will be $0.68 for 2028, with the lowest EPS forecast at $0.42, and the highest EPS forecast at $1.01. In 2029, PHR's EPS is forecast to hit $1.70 (min: $1.60, max: $1.82).

What is PHR's forecast return on equity (ROE) for 2027-2029?

(NYSE: PHR) forecast ROE is 13%, which is considered weak.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.